The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80.
Semiconductor Manufacturing International Corporation
0981.HK · UNKNOWN · USD · Market cap $550.5B
Semiconductor Manufacturing International Corporation, an investment holding company, engages in the manufacture, testing, and sale of integrated circuits wafer and various compound semiconductors in the United States, C…
PASS · Titan EthicalScreen close, 2026-09-22 · not a live quote
Last reviewed 14 days ago
Screened 2026-09-22 · the tape above runs as of 17:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 64.30 against the desk's fair-value range, base estimate 56.13, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Semiconductor Manufacturing International Corporation holds its Markdown at $64.30. Elevated stress, defensive posture warranted, held for 33 days.
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 33 days |
| Price at the screen | $64.30 |
| Valuation | 63.04 trailing · 35.85 forward price to earnings |
| Values screen | PASS |
| Beta | 0.36 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 24.10% | Below 33% | Interest-bearing debt is just 24.1% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 2.93% | Below 33% | Cash held in interest-bearing accounts and securities is 2.9% of assets, under the one-third limit. | Pass |
| Receivables | 12.91% | Below 49% | Money owed to the company is 12.9% of assets, under the 49% limit. | Pass |
| Revenue purity | 4.27% | Below 5% | Only 4.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Semiconductor Manufacturing International clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and interest is about 4% of its income, under the ~5% line, so it passes.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-22 screen. The gold marker is the market price at the same screen. The price runs 12.7% above the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits +51% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-22 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 35.9xfairly priced for its growth rate |
| Trailing P/E | 63.0xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.02 |
| EPS, forward | 1.79 |
| Revenue growth | +36.1%strong top-line growth |
| Profit margin | 10.0%thin but positive margins |
| Return on equity | 4.2%a modest return on shareholder capital |
| FCF yield | -0.75% |
| Debt to equity | 0.37minimal debt: a conservative balance sheet |
| Current ratio | 1.87healthy short-term liquidity |
| Beta | 0.36barely tracks the market's swings |
| 52-week range | 49.32 - 93.50 |
| Moat | NONE |
| Market cap | $550.5B |
The risks · The things to watch: its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade0981.HK trades on UNKNOWN (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.6% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 5.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (21 analysts) rates it buy, with a mean price target of $80. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- China chipmaking stocks tumble as Beijing reportedly mulls allowing Nvidia sales Investing.com · 9d ago
- Asia chip stocks slide as OpenAI pause revives AI slowdown fears Investing.com · 9d ago
- Entegris and Lattice Semiconductor Shares Are Soaring, What You Need To Know StockStory · 14d ago
- FormFactor, Kulicke and Soffa, Monolithic Power Systems, Micron, and Seagate Stocks Trade Up, What You Need To Know StockStory · 14d ago
- Taiwan Semiconductor Manufacturing's Foundry Market Share Is a Massive Moat Nobody Talks About Motley Fool · 16d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $76.60 | -5.6% | · | $945 | -5.6% |
| 2 months | $58.25 | +24.2% | · | $1,242 | +24.2% |
| 3 months | $63.10 | +14.7% | · | $1,147 | +14.7% |
| 6 months | $67.70 | +6.9% | · | $1,069 | +6.9% |
| 1 year | $41.45 | +74.6% | · | $1,746 | +74.6% |
| 2 years | $18.38 | +293.6% | · | $3,936 | +293.6% |
| 3 years | $21.15 | +242.1% | · | $3,421 | +242.1% |
| 5 years | $23.80 | +204.0% | · | $3,040 | +204.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever 0981.HK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.